• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
WANG Zhuo, WANG Zhanbo, CHENG Yanan, YOU Linjun, YANG Yong, WANG Guangji. Effects of schisandrin B on pharmacokinetics of doxorubicin in rats[J]. Journal of China Pharmaceutical University, 2018, 49(5): 610-615. DOI: 10.11665/j.issn.1000-5048.20180514
Citation: WANG Zhuo, WANG Zhanbo, CHENG Yanan, YOU Linjun, YANG Yong, WANG Guangji. Effects of schisandrin B on pharmacokinetics of doxorubicin in rats[J]. Journal of China Pharmaceutical University, 2018, 49(5): 610-615. DOI: 10.11665/j.issn.1000-5048.20180514
shu

Effects of schisandrin B on pharmacokinetics of doxorubicin in rats

More Information
    Graphical Abstract
    • Abstract
  • To investigate the effect of combination of schisandrin B and doxorubicin on the pharmacokinetic behavior of doxorubicin in SD rats. An LC-MS/MS method was established for the determination of doxorubicin and its main metabolite doxorubicinol in SD rats plasma. Separation was performed on Agilent Eclipse XDB-C18 column(100 mm×2. 1 mm, 3. 5 μm)using 0. 1% formic acid solution and acetonitrile as mobile phase with a liner gradient program. The ion transitions were performed under ESI position model at m/z 544. 2→397. 3(doxorubicin), m/z 546. 2→399. 2(doxorubicinol), m/z 528. 2→381. 2(daunorubicin, internal standard). Calibration curves of doxorubicin(0. 500-500 ng/mL)and doxorubicinol(0. 200-50. 0 ng/mL)showed good linear regression. The precision and accuracy met the requirements. The variation coefficient of extraction recovery and matrix effect was less than 15%. The AUC0-t of doxorubicin were(605. 69±145. 84)and(564. 53±23. 99)ng ·h/mL in alone and combined group, respectively. The AUC0-t of doxorubicinol were(26. 69±13. 41)and(29. 00±2. 78)ng ·h/mL, respectively. Results indicated that, schisandrin B had not affected the pharmacokinetic behavior of doxorubicin in SD rats.
    • FullText(HTML)
    • References (10)
  • [1]
    Binaschi M,Bigioni M,Cipollone A,et al.Anthracyclines:selected new developments[J].Curr Med Chem Anticancer Agents,2001,1(2):113-130.
    [2]
    Cochera F, Dinca D, Bordeievic DA, et al. Nebivolol effect on doxorubicin-induced cardiotoxicity in breast cancer[J].Cancer Manag Res,2018,16(10):2071-2081.
    [3]
    Caroline F.Thorn,Connie Oshiro,Sharon Marsh,et al.Doxorubicin pathways:pharmacodynamics and adverse effects[J].Pharmacogenet Genomics,2011,21(7):440-446.
    [4]
    Otero FJ,Boor PJ,Sheahan RG.Doxorubicin-induced cardiomyopathy[J].Am J Med Sci,2000,320(1):59-63.
    [5]
    Kim SY, Kim SJ, Kim BJ, et al. Doxorubicin-induced reactive oxygen species generation and intracellular Ca2+ increase are reciprocally modulated in rat cardiomyocytes[J].Exp Mol Med,2006,38(5):535-545.
    [6]
    Kotamraju S,Kalivendi SV,Konorev E,et al.Oxidant-induced iron signaling in doxorubicin-mediated apoptosis[J].Methods Enzymol,2004,378:362-382.
    [7]
    Lefrak EA,Pitha J,Rosenheim S,et al.A clinicopathologic analysis of adriamycin cardiotoxicity[J].Cancer,1973,32(2):302-314.
    [8]
    Hu KY,Yang Y,He LH,et al.Prevention against and treatment of doxorubicin-induced acute cardiotoxicity by dexrazoxane and schisandrin B[J].Acta Pharm Sin(药学学报),2014,49(7):1007-1012.
    [9]
    Wang Z,Wang ZB,Cheng YN,et al.Study on induction of cytochrome P450 enzymes by schisandrin B in vitro[J].J Pham Res(药学研究),2017,10:559-562.
    [10]
    Lai L,Hao H,Wang Q,et al.Effects of short-term and long-term pretreatment of schisandra lignans on regulating hepatic and intestinal CYP3A in rats[J].Drug Metab Dispos,2009,37(12):2399-2407.
    • Related Articles

  • Related Articles

    [1]ZENG Jingxia, ZHOU Wei, JIANG Yuteng, XUE Chunling. Antiviral and anti-inflammatory mechanism of Anti-601 Mixture based on network pharmacology and molecular docking[J]. Journal of China Pharmaceutical University, 2020, 51(5): 577-583. DOI: 10.11665/j.issn.1000-5048.20200509
    [2]ZHANG Min, LI Jingjing. Effect of licorice flavonoids as CDK1 inhibitors against liver cancer in vitro and in vivo[J]. Journal of China Pharmaceutical University, 2018, 49(1): 72-78. DOI: 10.11665/j.issn.1000-5048.20180110
    [3]YANG Hanbing, YANG Wenqiang, SONG Min, ZHANG Jian, ZHANG Xiaoqi, YE Wencai. Phenolic constituents of Galla Chinensis and their antiviral activities[J]. Journal of China Pharmaceutical University, 2016, 47(5): 566-569. DOI: 10.11665/j.issn.1000-5048.20160510
    [4]OU Yu, FU Xiaozhong, ZHA Yufeng, ZHANG Shun, SU Hang, DONG Yongxi. Synthesis and biological evaluation of mixed phosphonate derivatives of substituted acyclonucleoside phosphonates[J]. Journal of China Pharmaceutical University, 2014, 45(6): 649-656. DOI: 10.11665/j.issn.1000-5048.20140605
    [5]CAO Jin-ming, WU Yan-jun, ZHU Chong-quan, HUANG Wen-long. Synthesis and anti-virus activities of 1,2,4-oxadiazole-phenoxy alkyl-isoxazole derivatives[J]. Journal of China Pharmaceutical University, 2011, 42(4): 299-304.
    [8]Synthesis of Antiviral Agent Pleconaril[J]. Journal of China Pharmaceutical University, 2004, (5): 92-94.
    [9]Synthesis and Antiviral Activity of Astragalus mongholicus Polysaccharide Sulfate[J]. Journal of China Pharmaceutical University, 2002, (2): 68-70.
    [10]Studies of Antivirus Activities of Eight Kinds of Chinese Medicinal Herb[J]. Journal of China Pharmaceutical University, 1995, (1): 33-36.

Catalog

    Get Citation
    PDF
    XML
    Article views (831) PDF downloads (933) Cited by()
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    Copyright © Journal of China Pharmaceutical University苏ICP备12050101号-2

    Address：24 Tongjia Lane, Nanjing City, Jiangsu Province （210009）Tel: 025-83271566E-mail: xuebao@cpu.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    Total visits：300540

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return